INVO Bioscience (INVO) News Today → Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad) Free INVO Stock Alerts $1.37 -0.15 (-9.87%) (As of 04:00 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineMicro Cap Massively Bid Up Before Opening Bellmsn.com - April 17 at 2:16 PMWhy Invo BioScience Stock Is Soaring Todaybenzinga.com - April 17 at 1:54 PMmarketbeat.com - April 17 at 9:36 AMWhy Is Invo Bioscience (INVO) Stock Up 85% Today?msn.com - April 17 at 8:54 AMWhy Is Invo Bioscience (INVO) Stock Up 85% Today?investorplace.com - April 17 at 8:16 AMWhy INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarketbenzinga.com - April 17 at 7:07 AMAadi Bioscience, Inc. (AADI) Latest Stock News & Headlines - Yahoo Financefinance.yahoo.com - April 17 at 3:53 AMINVO Stock Earnings: INVO Bioscience Reported Results for Q4 2023msn.com - April 16 at 10:26 PMINVO Reports Fourth Quarter and Full Year 2023 Financial Resultsfinance.yahoo.com - April 16 at 5:25 PMShort Interest in INVO Bioscience, Inc. (NASDAQ:INVO) Expands By 10.0%americanbankingnews.com - April 16 at 4:24 AMASMB Assembly Biosciences, Inc.seekingalpha.com - April 4 at 7:57 AMINVO Bioscience Stock (NASDAQ:INVO), Short Interest Reportbenzinga.com - February 22 at 1:02 PMINVO Bioscience Inc INVOmorningstar.com - February 4 at 7:37 AMINVO BioScience Shares Up 5% as NAYA Agrees to Buy Florida Biotechnologiesmarketwatch.com - January 23 at 2:07 PMNAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)finance.yahoo.com - January 23 at 9:53 AMNAYA Biosciences To Acquire Clinical Stage Gene Therapy Program for Leber's Hereditary Optic Neuropathy (LHON)finance.yahoo.com - January 23 at 9:53 AMINVO Bioscience Files S-4 Registration and Preliminary Joint Proxy Statements in Connection with Merger with NAYA Biosciences, NAYA Announces New Board Directorsfinance.yahoo.com - January 17 at 10:29 AMINVO Bioscience, Inc. (INVO) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - December 23 at 1:02 PMNAYA Biosciences Announces Publication of New Data for its CD38-targeted Flex-NK™ Bispecific Antibody in the American Society of Hematology's Blood Journalfinance.yahoo.com - December 11 at 8:51 AMNAYA, ONK team up to evaluate potential cancer therapy combinationsmsn.com - December 6 at 4:01 PMNAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK™ Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therapiesfinance.yahoo.com - December 6 at 9:40 AMINVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirementfinance.yahoo.com - November 28 at 10:41 AMWhy INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarketbenzinga.com - November 14 at 8:42 AMINVO Reports Record Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 13 at 5:42 PMWhat's Going On With INVO BioScience Stock?msn.com - November 13 at 2:55 PMBestGrowthStocks.Com Issues Comprehensive Analysis Regarding INVO Biosciences Mergerfinance.yahoo.com - November 13 at 9:54 AMWhy Is Fertility Treatment-Focused Firm INVO Bioscience Stock Trading Over 100% Higher Today?benzinga.com - November 10 at 1:36 PMNAYA Biosciences and INVO Bioscience Announce Appointment of Dr. Peter Kash, Ed.D., MBA as Vice Chairman Following Closing of Their Pending Mergerfinance.yahoo.com - November 10 at 12:45 PMmarketbeat.com - November 10 at 11:18 AMmarketbeat.com - November 10 at 10:24 AMmarketbeat.com - November 10 at 10:19 AMmarketbeat.com - November 10 at 10:13 AMmarketbeat.com - November 10 at 10:13 AMmarketbeat.com - November 10 at 9:59 AMmarketbeat.com - November 10 at 9:37 AMINVO Bioscience Announces Commencement of Waiver Solicitation From Holders of the Company's Common Stock Purchase Warrantsfinance.yahoo.com - November 9 at 5:10 PMBHAT and INVO among pre-market losersmsn.com - October 30 at 9:00 AMFree Registration Is Now Open For Tribe Public's CEO and Q&A Presentation Webinar Event "Accelerating Biotech Value Creation" Featuring NAYA Biosciences CEO Dr. Daniel Teper On Tuesday, October 31, 2023finance.yahoo.com - October 27 at 10:32 AMINVO BIOSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of INVO Bioscience, Inc. - INVObusinesswire.com - October 24 at 10:39 PMWhy INVO BioScience Stock Dropped Today, Trading Also Halted Several Timesbenzinga.com - October 24 at 5:39 PMSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HES, ESMT, INVO, TGHstockhouse.com - October 24 at 12:38 PMmarketbeat.com - October 23 at 3:09 PMWhy Is INVO Bioscience (INVO) Stock Up 325% Today?msn.com - October 23 at 3:01 PMmarketbeat.com - October 23 at 1:37 PMINVO Bioscience Shares Take Flight on NAYA Biosciences Dealmarketwatch.com - October 23 at 1:09 PMmarketbeat.com - October 23 at 12:12 PMmarketbeat.com - October 23 at 11:56 AMmarketbeat.com - October 23 at 11:12 AMmarketbeat.com - October 23 at 11:05 AMmarketbeat.com - October 23 at 10:57 AM Get INVO Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for INVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Tiny Biotech Stock Wins $75 Billion Patent (Ad)A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda. Find out more here >>> INVO Media Mentions By Week INVO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INVO News Sentiment▼0.350.52▲Average Medical News Sentiment INVO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INVO Articles This Week▼101▲INVO Articles Average Week Get INVO Bioscience News Delivered to You Automatically Sign up to receive the latest news and ratings for INVO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ReShape Lifesciences News Today Dynatronics News Today Motus GI News Today Nemaura Medical News Today Bluejay Diagnostics News Today Quoin Pharmaceuticals News Today Tenon Medical News Today Sintx Technologies News Today Venus Concept News Today Aethlon Medical News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INVO) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe “Perfect Storm” for GoldGold Safe ExchangeThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTiny Biotech Stock Wins $75 Billion PatentBehind the MarketsBiden’s $374B Giveaway Into This SectorDTIYour Money is Not SafeAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceSHOCKING Crypto Leak…Crypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding INVO Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.